|
6 MGD的治疗
6.1 药物治疗 根据MGD发病机理，选择相应药物治疗：①对于睑缘炎、结膜炎局部药物有红霉素、四环素、妥布霉素、全身应用四环素和四环素族药物（强力霉素等）可以改善睑板腺分泌，抑制病原菌的脂肪酶活性，从而有效控制睑缘炎和MGD。②雄性激素治疗［23］：可改善泪膜结构，对睑板腺分泌功能有促进作用。
6.2 物理治疗［24］ 睑板按摩和热敷、红外线加热器或广谱加热器局部照射，促进睑板腺分泌物排出，使泪腺脂质层均匀，增加BuT，改善刺激症状。
6.3 支持治疗 包括泪小囊栓塞，口服亚油酸和亚油酸必需脂肪酸、N-乙酰半脱氨酸，达到增加泪膜稳定性的作用。
6.5 环境调节 改变生活工作习惯，缩短视频终端的使用时间，减少工作持续睁眼时间，减少泪膜蒸发［25］。
7 结语
MGD的病因多种多样，病理生理过程也十分复杂，且有多种分型，因此对此类疾病的治疗及疗效评价尚无统一标准，随着眼科学及其他边缘学科的发展，MGD越来越受到学者们的关注，将为干眼症的防治提供科学的依据。
【参考文献】
［1］ Bjerrum KB. Keratoconjunctivitis sicca and primary Sjogren's syndrome in a Danish population aged 30～60 years［J］. Acta Ophthalmol Scand, 1997,75(3):281-286.
［2］ Schein OD, Munoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly［J］. Am J Ophthalmol, 1997,124(6):723-728.
［3］ Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese eye centes［J］. Graefs Arch Clin Exp Ophthalmol, 1995,233(9):555-558.
［4］ McCarty CA, Bansal AK, Livingston PM, et al. The epidermiology of dry eye in Melbourne, Australia ［J］. Ophthalmology, 1998,105(6):1114-1119.
［5］ 张梅，陈家祺，刘祖国，等. 干眼患者115例的临床特点分析［J］. 中华眼科杂志，2003,39(1):5-9.
［6］ Jastaneiah S, Al-Rajhi AA. Association of aniridia and dry eyes［J］. Ophthalmolgy, 2005,112(9):1535-1540.
［7］ Schlote T, Kadner G, Freudenthaler N. Marked reduction and distinct patterns of eye blinking in patients with moderately dry eyes during video display terminal use ［J］. Graefes Arch Clin Exp Ophthalmol,2004,242(4):306-312.
［8］ Bron AJ, Tiffany JM, Gouveia SM, et al. Functional aspects of the tear film lipid layer［J］. Exp Eye Res, 2004,78(3):347-360.
［9］ Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on human meibomian gland and ocular surface［J］. J Clin Endocrinot Metab, 2000,85(12):4874-4882.
［10］ Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes［J］. Eye, 1991,5(pt 4):395-411.
［11］ Yokoi N, Komuro A. Non-invasive methods of assessing the tear film［J］. Exp Eye Res,2004,78(3):399-407.
［12］ Pflugfelder SC, Tseng SC, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear film disorders known to cause ocular irritation ［J］. Cornea,1998,17(1):38-56.
［13］ 吕中凡,瞿佳.干眼症的临床诊断研究［J］. 中国实用眼科杂志,2002,20(7):514.
［14］ 潘以方,王光萍.干眼症的检查［J］. 中国实用眼科杂志,2003,21(10):730-731.
［15］ Roth HW, Marquadt R. Micropachometric quantification of tera assessment tests ［J］. Adv Exp Med Biol,1998,438:883-886.
［16］ Mather WD, Lane JA, Zimmerman MB.Assessment of the tear film with tandem scanning confocal microscopy［J］. Cornea,1997,16(2):162.
［17］ Liu Z. Pflugfelcler SC. Corneal surface regularity and the Effect of artificial tears in aqueous tear deficiency ［J］. Ophthalmology,1999,106(5):939-943.
［18］ Gilbard JP, ScottR, Rossi SR, et al. Tear film and ocular surface changes after closure of the meibomian gland orifices in the rabbit ［J］. Ophthalmology, 1989,96(8):1180-1186.
［19］ 肖启国.干眼模型的建立方法及评价［J］. 眼科研究,2004,22(4):438-440.
［20］ Jester JV, Nicolaides N, Smith RE, et al. Meibomian gland dysfunction Ⅱ，the role of keratinazation in a rabbit model MGD［J］. Invest Ophthalmology, 1989,96(8):1180-1186.
［21］ Jester JV, Rajagopalan S, Rodrigues M, et al. Meibomian gland changes in the rhino mouse［J］. Invest ophthalmol vis sci, 1988,28(6):1190-1194.
［22］ Chan C, Gery I, Kohn L, et al. Periocular inflammation in mice with experimental systemic lupus erythematosus. A new experimental blepharitis and itsmodulation ［J］. J Immunot, 1995,154(9):4830-4835.
［23］ Foulks GN. Blepharitis: Lid Margin disease and the ocular surface［M］// In：Holland EJ. Ocular Surface Disease. Berlin: Springer, 2002:39-48.
［24］ Mori A, Oguchi Y, GotoE, et al. Efficacy and safety of infrared warming of the eyelids ［J］. Cornea,1999,18(2):188-193.
［25］ Gulati A, Tsubota K. Keratoconjunctivitis sicca：clinic aspects. In：Foster CS, Azar DT, Dohlman CH, eds. Smolin and Thoft's the cornea scientific foundations and clinical practice［M］. Fourth edition. Philadelphia：Lippincott Williams and Wilkins,2005:603-627. 上一页 [1] [2] |
